OncoImmune, Inc. — Form D
OncoImmune, Inc. of ROCKVILLE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2017-02-07. The offering totals $15.0M, of which $5.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-02-07
- Form: D
- Accession: 0001695528-17-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $15.0M
- Amount sold: $5.5M
- Remaining: $9.5M
- Minimum investment: $100K
- Investors: 3
- Date of first sale: 2017-01-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-280152
Issuer
- Name: OncoImmune, Inc.
- CIK: 0001695528
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 9430 Key West Ave., ROCKVILLE, MD, 208507
- Phone: 301-557-9119
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Yang Liu | Director | HONG KONG, K3 |
| Yang Liu | Executive Officer | HONG KONG, K3 |
| Miao Hong | Director | Durham, NC |
| Martin Devenport | Executive Officer | Rockville, MD |
| KAREN LIU | Director | SAN DIEGO, CA |
| Gary Fanger | Director | Rockville, MD |
| Pan Zheng | Executive Officer | Rockville, MD |
| Kun-Liang Guan | Director | Rockville, MD |
Other filings by this issuer (2)
More